glp-1 eye rot Ozempic Blindness Lawsuit [2026 Update] Diabetic patients taking GLP-1s may

Tsukasaki and Takayanagi, 2019)

The FDA has classified it as a substance with potentially significant safety risks , warning of possible immune reactions and a lack of safety data

Additionally, stopping either medication abruptly may lead to other complications like antidepressant discontinuation syndrome or Adderall withdrawal

Most users notice visible improvements in 36 weeks of consistent use

Because both blend components are short-acting, a before-sleep model produces a co-timed pulse that rises and falls within the early-sleep window consistent with the preserved-pulsatility findings from the CJC-1295 literature, in which stimulation raised GH output while the underlying pulsatile pattern was maintained